Lyka Labs Limited (NSE:LYKALABS)
57.84
-0.09 (-0.16%)
Jun 3, 2026, 3:27 PM IST
Lyka Labs Revenue
In the fiscal year ending March 31, 2026, Lyka Labs had annual revenue of 1.28B INR, down -4.78%. Lyka Labs had revenue of 280.31M in the quarter ending March 31, 2026, a decrease of -6.04%.
Revenue
1.28B
Revenue Growth
-4.78%
P/S Ratio
1.61
Revenue / Employee
2.57M
Employees
499
Market Cap
2.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.28B | -64.55M | -4.78% |
| Mar 31, 2025 | 1.35B | 287.16M | 27.04% |
| Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
| Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
| Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biocon | 169.27B |
| Dishman Carbogen Amcis | 29.32B |
| Anthem Biosciences | 21.24B |
| OneSource Specialty Pharma | 14.37B |
| Concord Biotech | 10.55B |
| Blue Jet Healthcare | 9.47B |
| Supriya Lifescience | 8.28B |
| Panacea Biotec | 6.57B |
Lyka Labs News
- 10 months ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 1 year ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn